Advertisement ANSYS - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

ANSYS

Pharmaceutical Engineering Simulation Software

Logo
WHITE PAPERS
Quick Contact ANSYS
LATEST PRESS RELEASES
August 11, 2010

ANSYS, Inc. Reports Continued Growth Momentum in Second Quarter 2010

ANSYS, Inc., announced on 5 August in-line performance against its outlook in revenue and over-performance in non-GAAP EPS for the...
pharmacuetical business review
August 11, 2010

ANSYS Releases Ansoft Designer 6.0 with Solver on Demand Technology Integrating HFSS and HSPICE

New technology creates "best practice" for signal- and power-integrity analysis.
pharmacuetical business review


LATEST VIDEOS

ANSYS

ANSYS, Inc. develops and distributes engineering simulation software capable of reproducing, with great accuracy, numerous processes involved in pharmaceutical, biomedical and biotechnology applications.

By running structural analysis, fluid flow or fatigue and electromagnetic modeling, our users can quickly reach indepth understanding of complex processes such as drug delivery, pharmaceutical mixing, stent deployment, and orthopaedic prosthesis behavior for various patient activities. Our clients increasingly use virtual prototyping to save cost and reduce time to market.

Virtual prototyping for drug patents

Bringing a new drug or biomedical product to the market is a huge investment and a major risk. The design, manufacturing and approval processes for a new drug can take more than ten years and cost more than $1B; with a 15-year patent limit, this leaves pharmaceutical companies with only a few years to recoup development costs. These extremely high development costs and lengthy clinical trials drive up the price of drugs and often discourage pharmaceutical companies from risking the considerable resources required for an uncertain return on investment on innovative therapies. With several important drugs’ patents expiring within the next few years, companies are looking for ways to cut costs and time to market while opening doors to innovations.

Engineering simulation and electromagnetic modeling

Engineering simulation is increasingly perceived as the most promising technology to address these challenges. Using computational fluid dynamics (CFD) makes it possible to predict the behavior of blood flow in or around cardiovascular devices, turbulent air flow in inhalers and human upper airways, powder and spray mixing and more. Structural analysis provides detailed information about structural behavior of solid bodies submitted to various loads and constraints, whatever the complexity of the material behavior. Electromagnetic modeling gives insight on thermal cooling problems, signal integrity and signal interference between devices; fatigue analysis estimates the lifespan of implantable devices submitted to periodic or random loads.

Virtual prototyping

The ANSYS portfolio of engineering simulation software provides its users with fully tested and validated solutions for each of these challenges in an integrated framework. Within a single environment, users of ANSYS software can develop accurate and reliable virtual prototypes of products or processes, which often involve interaction between fluids, structures and electromagnetics. Because fewer physical prototypes need to be developed for testing, virtual prototyping is very cost effective.

Simulation models

A very large number of geometries, materials and operating conditions can be automatically tested in an optimization loop so that only the best designs are selected for final physical prototype validations. Furthermore, an in-depth understanding of mixing or drug delivery processes greatly facilitates FDA approval because it is easier to demonstrate end-product characteristics when details of entire processes can be comprehensively analyzed and visualized. With 40 years of experience in not only healthcare but also in industries such as aeronautics, automotive, electronics and energy, ANSYS has built a large user base and developed the most advanced simulation models currently available in a commercial code.

ANSYS customers experience unprecedented opportunities for innovations, which gives them a sustainable competitive edge and the chance to cost-effectively develop solutions for new markets previously considered unprofitable. This results in an acceleration of progress for the healthcare industry and better healthcare delivery to consumers.

ANSYS, Inc.
Southpointe
275 Technology Drive
Canonsburg, PA 15317

Tel: +1 724 746 3304
Fax: +1 724 514 9494
ansysinfo@ansys.com
www.ansys.com

ANSYS Portfolio of Products and Services

The portfolio of software and services from ANSYS is comprised of various codes accessed from the same environment and using the same pre- and post-processing tools to facilitate the work of its users. When modeling complex multiphysics situations, these tools can interact together in the same model to address the different facets of the applications with great accuracy.

ANSYS® AUTODYN® ANSYS AUTODYN is the code of choice to model high-speed impact processes such as blast, explosion, crash and typical drop tests or impact tests to which health care products are submitted to during the approval process. ANSYS® CFDâ„¢ ANSYS CFD provides access to both ANSYS® FLUENT® and ANSYS® CFX®, best-in-class tools for modeling…
Quick Contact ANSYS
Quick Contact ANSYS
Quick Contact ANSYS


Quick Contact ANSYS
Quick Contact ANSYS
Quick Contact ANSYS


Contact ANSYS

Optional Data

Almost there, complete this form and hit the submit button to complete your registration.

Confirmation

Finally, complete a quick security check and confirm terms and conditions:

Quick Contact ANSYS